| Nanocomposite‐based photodynamic therapy strategies for deep tumor treatment J Hu, Y Tang, AH Elmenoufy, H Xu, Z Cheng, X Yang Small 11 (44), 5860-5887, 2015 | 275 | 2015 |
| Highly Efficient FRET System Capable of Deep Photodynamic Therapy Established on X-ray Excited Mesoporous LaF3:Tb Scintillating Nanoparticles Y Tang, J Hu, AH Elmenoufy, X Yang ACS applied materials & interfaces 7 (22), 12261-12269, 2015 | 160 | 2015 |
| A novel deep photodynamic therapy modality combined with CT imaging established via X-ray stimulated silica-modified lanthanide scintillating nanoparticles AH Elmenoufy, J Hu, H Xu, X Yang Chemical Communications 51 (61), 12247-12250, 2015 | 91 | 2015 |
| Computer‐aided drug design of small molecule inhibitors of the ERCC1‐XPF protein–protein interaction F Gentile, AH Elmenoufy, G Ciniero, D Jay, F Karimi‐Busheri, KH Barakat, ... Chemical Biology & Drug Design 95 (4), 460-471, 2020 | 29 | 2020 |
| Targeting DNA repair in tumor cells via inhibition of ERCC1–XPF AH Elmenoufy, F Gentile, D Jay, F Karimi-Busheri, X Yang, OM Soueidan, ... Journal of Medicinal Chemistry 62 (17), 7684-7696, 2019 | 26 | 2019 |
| Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1–XPF-mediated DNA repair G Ciniero, AH Elmenoufy, F Gentile, M Weinfeld, MA Deriu, FG West, ... Cancer Chemotherapy and Pharmacology 87, 259-267, 2021 | 18 | 2021 |
| Design, synthesis and in vitro cell-free/cell-based biological evaluations of novel ERCC1-XPF inhibitors targeting DNA repair pathway AH Elmenoufy, F Gentile, D Jay, F Karimi-Busheri, X Yang, OM Soueidan, ... European Journal of Medicinal Chemistry 204, 112658, 2020 | 12 | 2020 |
| Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains C Weilbeer, D Jay, JC Donnelly, F Gentile, F Karimi-Busheri, X Yang, ... Frontiers in Oncology 12, 819172, 2022 | 10 | 2022 |
| “Pyridopyridazine”: A Versatile Nucleus in Pharmaceutical Field MA Ibrahim, AH Elmenoufy, M Elagawany, MM Ghoneim, A Moawad Journal of Biosciences and Medicines 3 (10), 59-66, 2015 | 8 | 2015 |
| Recent advances in structure-based protein engineering MM Rahman, I Sarker, AH Elmenoufy, HS Bahlol, S Zaman Sch J Appl Med Sci 3, 1224-1237, 2015 | 3 | 2015 |
| Targeting dna repair in tumor cells via inhibition of ercc1-xpf F West, J Tuszynski, M Weinfeld, KH Barakat, AH Elmenoufy, F Gentile, ... | 1 | 2020 |
| The synergy between alkylating agents and ERCC1–XPF inhibitors is p53 dependent G Ciniero, TM Pedro, C Dumontet, AH Elmenoufy, FG West, M Weinfeld, ... Fundamental & Clinical Pharmacology 39 (1), e13043, 2025 | | 2025 |
| Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics P Mehinrad, A Abdelfattah, S Sadat, T Shafaati, AH Elmenoufy, D Jay, ... Drug Delivery and Translational Research, 1-15, 2025 | | 2025 |
| Bypassing cancer drug resistance mechanisms by tuning ERCC1-XPF and p53 activity G Ciniero, F Gentile, AH Elmenoufy, E Cros-Perrial, FG West, M Weinfeld, ... CANCERTO-NANOSCIENCE IN CANCER IMMUNOTHERAPY, 63, 2023 | | 2023 |
| Targeting cancer drug resistance by modulation of ERCC1-XPF and p53 activity G Ciniero, F Gentile, AH Elmenoufy, E Cros-Perrial, FG West, M Weinfeld, ... Biomedical Science and Engineering 2 (1), 2021 | | 2021 |
| Design, Synthesis, and Biological Evaluation of Compounds for DNA Targeted Therapy AHM Elmenoufy | | 2020 |
| Supporting Information Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPF AH Elmenoufy, F Gentile, D Jay, F Karimi-Busheri, X Yang, OM Soueidan, ... | | |
Michael WeinfeldDepartment of Oncology, University of AlbertaVerified email at ualberta.ca
